Anjan Selz

home / authors / anjan-selz

Anjan Selz is CEO and co-founder of Finox Biotech

Articles

Site Logo

The Drive for Best Practice in Biopharmaceutical Manufacturing

Anjan Selz
March 1st 2012

Key business considerations when developing biosimilar products virtually.

BioPharmSubscribe-756496-1408612816519.jpg

Biosimilar development in a virtual biotech set-up - Part I

Anjan Selz
December 5th 2011

How does working in a virtual biotech environment affect biosimilar development? Anjan Selz outlines target and partner selection in this first of a two part article.

BioPharmSubscribe-756691-1408612571921.jpg

Biosimilar Development in a Virtual Biotech Environment - Part II

Anjan Selz
December 5th 2011

Virtual biotech CEO Anjan Selz focuses on product development, credibility and differentiation.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: October 28th 2024 | Updated: November 22nd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 22nd 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 22nd 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 22nd 2024 | Updated: November 22nd 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
© 2024 MJH Life Sciences

All rights reserved.